Ireland· IE-PA-PA22998/002/001
Slyndy 4 mg film-coated tablets
A qg03ac10 product containing drospirenone, registered in Ireland by Exeltis Healthcare S.L..
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Drospirenone
- Manufacturer
- Exeltis Healthcare S.L.
- Country
- Ireland (IE)
- ATC code
- QG03AC10
- ATC class
- QG03AC10
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22998/002/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Drospirenone in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandSlinda 4.0 mg, FilmtablettenExeltis Suisse SA
- CzechiaZLYNDAExeltis Czech s.r.o., Praha
- SpainSLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULAExeltis Healthcare S.L.
- FinlandSlindaExeltis Healthcare S.L.
- FranceSLINDA 4 mg, comprimé pelliculéEXELTIS SANTE
- IcelandSlindaExeltis Healthcare S.L.*
- NetherlandsSlinda 4 mg filmomhulde tablettenExeltis Healthcare S.L
- PolandSlindaExeltis Poland Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4adb2c8-b6f8-4344-a8bc-fc1b4ac71090 GET /v1/drugs/b4adb2c8-b6f8-4344-a8bc-fc1b4ac71090?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"QG03AC10"
],
"strength": null,
"pa_number": "PA22998/002/001",
"substances": [
"Drospirenone"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "23/07/2021",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about drospirenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.